Developing a genetic system for functional manipulations of \u3ci\u3eFUM1,\u3c/i\u3e a polyketide synthase gene for the biosynthesis of fumonisins in \u3ci\u3eFusarium verticillioides\u3c/i\u3e by Yu, Fengan et al.
University of Nebraska - Lincoln 
DigitalCommons@University of Nebraska - Lincoln 
Liangcheng Du Publications Published Research - Department of Chemistry 
2-4-2005 
Developing a genetic system for functional manipulations of 
FUM1, a polyketide synthase gene for the biosynthesis of 
fumonisins in Fusarium verticillioides 
Fengan Yu 
University of Nebraska - Lincoln, fyu2@unl.edu 
Xiangcheng Zhu 
University of Nebraska - Lincoln 
Liangcheng Du 
University of Nebraska-Lincoln, ldu3@unl.edu 
Follow this and additional works at: https://digitalcommons.unl.edu/chemistrydu 
 Part of the Chemistry Commons 
Yu, Fengan; Zhu, Xiangcheng; and Du, Liangcheng, "Developing a genetic system for functional 
manipulations of FUM1, a polyketide synthase gene for the biosynthesis of fumonisins in Fusarium 
verticillioides" (2005). Liangcheng Du Publications. 4. 
https://digitalcommons.unl.edu/chemistrydu/4 
This Article is brought to you for free and open access by the Published Research - Department of Chemistry at 
DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Liangcheng Du Publications 
by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln. 
1  Introduction
Filamentous fungi are rich sources for polyketide metab-
olites, some of which have important biological activities 
[1]. Among them, fumonisins are a group of mycotoxins 
produced by Fusarium verticillioides, which cause sever-
al fatal animal diseases, including leukoencephalomalacia 
in horses [2, 3], pulmonary edema in swine [4], and can-
cer in rats [5]. In addition, fumonisins are associated with 
human esophageal cancer [6, 7].
Polyketides are biosynthesized through sequential decar-
boxylative condensations of short carboxylic acids, which is 
catalyzed by polyketide synthases (PKSs) [8]. Recently, sev-
eral genomes of fi lamentous fungi have been sequenced. The 
sequencing data revealed a large number of putative PKS 
genes existing in fi lamentous fungi [9]. These fungal PKS 
genes outnumber those found in the genomes of Streptomyces 
avermitilis[10] and Streptomyces coelicolor[11], actinomy-
cete species that are traditionally regarded as the most abun-
dant source for polyketide metabolites. Fungal PKSs are clas-
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Abstract: Fumonisins are mycotoxins produced by Fusarium verticillioides, a fi lamentous fungus that 
is a widespread pathogen of corn. The biosynthesis of fumonisins is catalyzed by an iterative modular 
polyketide synthase (PKS). The study of the biosynthetic mechanism for these reduced fungal polyketides 
has been challenging due to the diffi culties in detecting the intermediates with a linear carbon chain and 
manipulating the 7-domain PKS gene from the fi lamentous fungus. Here, we described the development of 
a genetic system for functionally manipulating the methyltransferase domain of FUM1 that is responsible 
for the assembly of a dimethylated 18-carbon chain. Using a two-stage screening strategy, including both 
positive and negative screenings, we were able to generate mutant strains with a specifi cally changed 
active-site in FUM1. LC-MS analyses indicated that biosynthetic intermediates were detectable in the 
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sifi ed into three groups: (i) PKSs for single aromatic ring; (ii) 
PKSs for polycyclic aromatic ring; and (iii) PKSs for reduced 
complex-polyketides [12, 13]. They are defi ned as iterative 
type I PKSs because they usually contain only a single set of 
domains, in contrast to the non-iterative modular type I PKSs 
and monofunctional type II PKSs found in bacteria [1]. Typi-
cally, a module consists of a β-ketoacyl synthase (KS), an ac-
yltransferase (AT), and an acyl carrier protein (ACP). Many 
PKSs, especially those for reduced polyketides, also contain 
additional domains, such as β-ketoacyl reductase (KR), de-
hydratase (DH), enoylreductase (ER), and methyltransferase 
(MT) (Fig. 1). A single-modular PKS can catalyze multiple 
cycles of chain elongation [1, 14].
Although information for the biosynthetic mechanism 
for aromatic fungal polyketides has begun to emerge in 
the recent years [15–22], the mechanism for the reduced 
polyketides remains unknown. Two major diffi culties are as-
sociated with the studies of the reduced fungal polyketides. 
One is due to the structural feature of the metabolites, 
which often have a linear carbon backbone resembling fat-
ty acids. This feature not only makes their detection diffi -
cult but also often leads to no intermediates accumulated 
in the gene-disruption mutants because the putative precur-
sors could be utilized by other pathways. Another diffi culty 
is related to the genetic manipulation of the multi-domain 
genes in fi lamentous fungi. The PKS genes responsible for 
the biosynthesis of reduced fungal polyketides are more 
complex than those for aromatic polyketides. For example, 
FUM1 responsible for assembling the 18-carbon chain of 
fumonisins in F. verticillioides was predicted to code sev-
en domains, KS–AT–DH–MT–ER–KR–ACP (Fig. 1) [23]. 
The gene-disruption approach, most commonly through 
inserting a selection marker, such as hygromycin [23, 24] 
or a phleomycin [25] resistance gene into the target gene, 
has been performed to study this group of PKSs. However, 
this type of manipulations could only provide evidence for 
the relatedness of the PKS gene to the biosynthesis of the 
metabolite. In this study, our goal was to develop a genet-
ic system for functionally manipulating the individual do-
mains of the fungal PKS for reduced polyketides. Reported 
here are results obtained from an active-site point mutation 
of the methyltransferase domain of FUM1.
2  Materials and methods
2.1 Strains and culture media
F. verticillioides wild-type strain A0149 (FGSC number 
7600) was provided by Dr. David Gilchrist (University of 
California, Davis). YPD medium and V-8 juice agar were 
used to produce mycelia and conidia [23], and cracked 
maize kernels (CMK) for fumonisin production [23, 26].
2.2 DNA manipulation and construction of plasmids
Escherichia coli DH5-α strain was used as the host for 
general DNA preparation, and the pGEM-zf series from Pro-
mega (Madison, WI) for cloning and DNA sequencing. Plas-
mid preparation and DNA extraction were carried out with 
Qiagen kits (Valencia, CA), and all other manipulations were 
carried out according to standard methods [27]. To introduce 
site directed mutagenesis at the S-adenosylmethionine (SAM) 
binding site of the FUM1 MT domain, pUCHΔmt was con-
structed by means of SOE (splicing by overlap extension) 
[28], involving three PCR amplifi cations. The fi rst PCR was 
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carried out with Cos6B as template [23], using primers MT1 
and MT2 (Table 1). The 1187-bp product (mt1) contained a 
point mutation introduced by the MT2 primer, in which the 
original sequence, 5’-GGCACC-3’, in the SAM binding motif 
of the MT domain was changed to 5’-AAGCTT-3’ (Gly1470–
Thr1471 of Fum1p changed to Lys1470–Leu1471). This change 
also created a Hin dIII site to facilitate the mutant identifi ca-
tion in the later stage. The second PCR was similarly carried 
out using primers MT3 and MT4 to produce a 1185-bp prod-
uct (mt2). The third PCR used the mixture of mt1 and mt2 as 
templates and MT1 and MT4 as primers to get the fi nal 2352-
bp product. The fragment was digested with Eco RI/Kpn I 
and cloned into the same sites of pT7Blue–3 (Novagen) for 
sequencing and further into Sal I/Kpn I sites of pUCH2-8 
[23] to yield pUCHΔmt. This construct contains an E. coli 
hygromycin B resistance gene (Hyg B) fused to the Promoter 
1 from C. heterostrophus[29] (Fig. 2).
2.3 Transformation of F. verticillioides
The protocol used to isolate and transform protoplasts 
was similar to that described by Salch and Beremand 
[30] with the following modifi cations. Conidia were ger-
minated in fl ask containing 30 ml liquid YPD medium 
on a 120 rpm rotary shaker at 30°C for approximately 
7–8 h. The conidia were collected and digested at 30°C 
for 30–60 min in 20 ml of 0.7 M NaCl containing 5 mg/
ml Novozyme (Sigma), 25 mg/ml driselase (Sigma), and 
0.5 mg/ml chitinase (Sigma). For transformation, 5 μg of 
plasmid DNA was diluted with an equal volume of 2× 
STC buffer to 100 μl and mixed with 100 μl protoplasts, 
and transformation was mediated with PEG 8000 buf-
fer (30% PEG 8000; 10 mM Tris–HCl, pH 8.0; 50 mM 
CaCl2). The protoplast–DNA mixture was added to 4.5 
ml molten regeneration medium and dispensed onto the 
surface of 20 ml solidifi ed regeneration medium. After 
an overnight incubation, this regeneration medium was 
overlaid with 10 ml of 1% water agar supplemented with 
525 μg/ml hygromycin B (Calbiochem, La Jolla, CA), 
making the fi nal concentration of hygromycin B to 150 
μg/ml. Hygromycin-resistant colonies appeared on the 
plates in approximately 7 days of incubation at 28°C.
2.4 Screening of F. verticillioides mutants
The screening of mutants involves two stages. The fi rst 
stage is to select for gene disruption mutants resulted from 
a single crossover of the homologous regions. The hygro-
mycin-resistant colonies on YPD plates were transferred 
to a 2 ml YPD liquid medium supplemented with 300 μg/
ml of hygromycin B for further selection. Single conid-
ia were isolated from the surviving colonies, and the cul-
ture grown from the conidia were subjected to PCR and 
Southern analysis to identify the gene disruption mutants. 
In the second stage, the mutants were selected for the loss 
of hygromycin B resistance. Single conidia-derived cul-
tures were allowed to grow in 250-ml Erlenmeyer fl asks 
containing 50 ml liquid YPD medium without hygromycin 
B. After fi ve-day growth, a 50-μl of the culture was trans-
ferred to a 50-ml fresh liquid YPD medium. The trans-
fer process was repeated every fi ve days. After 4–5 seri-
al transfers, the culture was serial-diluted and spread on 
YPD plate to produce single colonies. The individual sin-
gle colonies were then replica-plated on two YPD plates, 
one with hygromycin B and one without. After two-day 
growth, colonies that did not grow on the plate with hy-
gromycin B but grew on the plate without hygromycin B 
were selected as putative gene replacement mutants.
2.5 Southern hybridization
Genomic DNA of F. verticillioides was prepared as 
described previously [31]. ImmobilonTM–NY+ Trans-
fer Membrane (Millipore, Bedford, MA) was used for 
blot analysis. Southern hybridization was performed us-
ing DIG DNA Labeling and Detection Kit (Roche, India-
napolis, IN) according to the manufacturer’s manual. Ten 
micrograms of genomic DNA was used in the hybridiza-
tions. Two 1.2 kb probes (mt1 and mt2, Fig. 2) were am-
plifi ed by PCR using primers MT1-MT2 and MT3-MT4 
(Table 1), respectively, with Cos6B as template.
2.6 Co-culture of mutants and analysis of metabolites
The procedure for co-culturing the MT mutant with 
FUM6 mutant is identical to that described previously 
[32]. FUM6 is a F. verticillioides mutant generated by re-
placing part (1.5 kb) of the coding region of FUM6 gene 
with the hygromycin resistance gene (Hyg B) [33]. For 
metabolite production and analysis, the single-conid-
ia derived strains were inoculated in 25 g CMK medi-
um and allowed to grow at 25°C in dark for 3–4 weeks 
as described previously [32]. The CMK cultures were 
extracted with water/acetonitrile (1:1, v:v). The extracts 
were fi ltered and subjected to HPLC-ELSD (high per-
formance liquid chromatography-evaporative light scat-
tering detection) or LC-ESMS (liquid chromatography-
electrospray mass spectrometry) analysis using the same 
procedures described previously [32].
3  Results and discussion
3.1 Development of the screening procedure for mutants
Our goal was to specifi cally change the active site of 
a PKS domain so that a fungal strain with a non-func-
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tional PKS domain would be generated. In order to 
reach this goal, the fi rst thing was to develop a relative-
ly effi cient and reliable screening procedure suitable for 
this fi lamentous fungus. Both positive (the fi rst stage) 
and negative (the second stage) screenings are required 
in order to identify the mutant. Therefore, the one-stage 
protocol developed previously [23] to screen resistant 
colonies will not be appropriate for our purpose. In the 
fi rst stage screening, approximately 3–7 hygromycin-re-
sistant colonies were obtained in a typical transforma-
tion using 5 μg of plasmid DNA and 107 protoplasts. The 
colonies resulted from plasmid DNA integration into the 
fungal genome. PCR was used to identify those resulted 
from a homologous recombination. The primers LMT1–
LMT2 and RMT1–RMT2 (Table 1) were used to detect 
the mutants with a crossover at the upstream (Fig. 2B) 
and the downstream (Fig. 2C), respectively, homologous 
regions. The engineered Hin dIII site in the mutated MT 
domain was used to distinguish the mutants from the 
wild-type. Using this selection approach, we obtained 
four mutants, mt-7, mt-21, mt-42, and mt-52, from 70 
hygromycin-resistant colonies. Mutant mt-42 gave a 1, 
473-bp PCR product when the fi rst pair of primers was 
used (data not shown). The product was digested by Hin 
dIII to give two fragments of 204 and 1269-bp, indicat-
ing a homologous recombinant resulting from a cross-
over at the upstream homologous region (Fig. 2B). In 
contrast, the PCR products from the wild type or those 
resulted from random insertions were not digestible by 
the enzyme although the products were the same size 
(data not shown). Mutant mt-7, mt-21, and mt-52 gave 
a 1, 689-bp PCR product when the second pair of prim-
ers was used. A digestion of the product by Hin dIII 
gave two DNA fragments with the expected size of 376 
and 1, 313-bp (data not shown), indicating a crossover 
at the downstream homologous region. After the single 
crossover mutants were confi rmed, they were grown on 
YPD medium without hygromycin B to select for a sec-
ond homologous recombination, which will generate ei-
ther the MT point mutant or reversed mutant (the wild 
type). Among 1, 880 single colonies that were derived 
from four gene-disrupted mutants, 32 lost hygromycin B 
resistance. Among them, 14 were identifi ed as MT point 
mutants by PCR and Southern analysis, and the rest 
were reversed mutants. Two representative Southern hy-
bridization results are shown in Fig. 2E and F. When the 
genomic DNA of the mutants was digested with Hin dIII 
and hybridized with mt1 and mt2 probe, the MT point 
mutants exhibited 1.3 and 2.1 kb signals, respectively, 
while the wild type gave a 3.4 kb signal when hybrid-
ized with either of the probes (Fig. 2). Thus, the mutants 
contain a point mutation at the active site of the MT do-
main of FUM1 in F. verticillioides.
3.2 Metabolite analysis in MT mutants
The fourteen MT point mutants and the 4 gene disrup-
tion mutants (mt-7, mt-21, mt-42, and mt-52) were inocu-
lated in CMK medium for 3 weeks for the metabolite anal-
ysis. The wild-type strain produced a characteristic pattern 
of fumonisins. FB1 was the predominant metabolite with a 
[M + H]+ of m/z 722.8 (Fig. 3A and B), whereas FB3 and 
FB2 were two minor peaks with the same [M + H]
+ of m/z 
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706.9 (Fig. 3A and C). As expected, the 4 gene disruption 
mutants did not produce any fumonisins (data not shown).
In the point mutants, no fumonisin was detected, whereas 
approximately 4 unknown peaks appeared on LC-MS. One 
of them gave a [M + H]+ of m/z 679.8, which was most 
close to that of demethylated FB3 or FB2. However, exten-
sive MS–MS analyses showed that none of the compounds 
had the linear carbon skeleton of fumonisins. Therefore, no 
detectable amount of fumonisins or the demethylated an-
alogs was produced in the point mutants. Two possibili-
ties exist for the result. One is that the point mutation at 
the MT active site resulted in an inactive Fum1p. Anoth-
er possibility is that the putative demethylated interme-
diate (stearyl) that was assembled by the point-mutated 
Fum1p was not recognized by downstream enzymes, such 
as Fum8p and Fum6p, in the pathway (Fig. 4). Alternative-
ly, the C18-intermediate could be a substrate for fatty acid 
metabolic pathways, such as the β-oxidation. Intermediates 
derailed into other pathways are not uncommon in fungal 
polyketide biosynthesis [34]. This is possible especially 
when the mutants were allowed to grow a prolonged peri-
od of time. In order to test if the point-mutated Fum1p was 
active, we adopted the co-culture approach. This approach 
enables two different FUM mutant strains to functionally 
complement each other, so that the fi nal metabolites, which 
are much more stable and easier for detection, could be 
produced [32]. When the MT point mutant of FUM1 was 
co-cultured with the FUM6-deleted mutant [33], FB1 was 
clearly produced in the culture (data not shown). The fact 
that the fumonisin production was restored in the co-cul-
tures indicated that downstream enzymes were functional 
in the MT point mutant because it was able to convert the 
intermediates produced by the FUM6 mutant to the fi nal 
product. As reported previously [32, 33], the culture of the 
FUM6 mutant alone did not accumulate any detectable in-
termediates when it was allowed to grow for 2–4 weeks. 
Several small peaks were observed on LC-MS from the 
culture of the FUM6 mutant that was 3–7 days old (Fig. 
3D). These peaks eventually disappeared if the culture 
was allowed to grow longer, as observed previously [32].
To gain more information, we analyzed the metabolites 
in the co-cultures 3–7 days after inoculation. Our previous 
experience with these mutants showed that intermediates 
were accumulated only at the early stage of the cultures 
[32]. Similar to those observed when the deletion mutants 
of FUM1 and FUM6 were co-cultured [32], the 3 to 7-day 
old co-cultures of MT mutant and FUM6 mutant produced 
the normal (methylated) intermediates. For example, the 
peak with a [M + H]+ of m/z 340.3 was predicted for the 3-
keto intermediate (Figs. 3E and G and 4), whereas the peak 
with a [M + H]+ of m/z 390.4 for a tetrahydroxylated inter-
mediate (Fig. 3E and H) [32]. In addition to these previous-
ly observed peaks, the co-cultures also contained several 
peaks with mass corresponding to demethylated interme-
diates. For example, the peak with a [M + H]+ of m/z 312.3 
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is corresponding to the demethylated 3-keto intermediate 
(Figs. 3E and F and 4), and the peak with a [M + H]+ of m/
z 330.3 to the demethylated dihydroxy intermediate (Fig. 
3E and I). The yield of these intermediates in the mutants 
was extremely low and eventually disappeared in the older 
cultures. Nevertheless, the results suggest that FUM1 with 
a MT point mutation was functional. The results also sug-
gest that the putative demethylated C18 intermediate pro-
duced in the MT mutant might be further metabolized by 
other pathways. Interestingly, the demethylated intermedi-
ates were not observed when the MT mutant was cultured 
alone. The reason for this result is not clear, but might be 
related to the inability of the culture to produce the more 
stable, normal (methylated) intermediates of fumonisin, as 
expected when co-cultured with FUM6 mutant [32].
In bacteria, the genetic manipulation of PKS domains 
has proven a powerful way to elucidating the domain struc-
ture and function of PKSs [1, 8]. Recently, this approach 
also has been successfully used in the studies of aromat-
ic fungal polyketides [15, 21]. However, this type of genet-
ic manipulations has not been conducted in reduced fungal 
polyketides due to inherent diffi culties in detecting the me-
tabolites and the lack of an effi cient genetic system for the 
fi lamentous fungi. In this work, we have developed a genet-
ic system through point mutating the active site of the MT 
domain of FUM1 in F. verticillioides. This system should 
be useful in studies of the biosynthetic mechanism of fu-
monisins as well as other similar fungal polyketides, im-
plied by the large number of PKSs discovered in genome 
sequencing projects of fi lamentous fungi.
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